prokineticin-2β



prokineticin-2β

A1AA1V2VV2I3II3T4TT4G5GG5A6AA6C7CC7D8DD8K9KK9D10DD10S11SS11Q12QQ12C13CC13G14GG14G15GG15G16GG16M17MM17C18CC18C19CC19A20AA20V21VV21S22SS22I23II23W24WW24V25VV25K26KK26S27SS27I28II28R29RR29I30II30C31CC31T32TT32P33PP33M34MM34G35GG35K36KK36L37LL37G38GG38D39DD39S40SS40C41CC41H42HH42P43PP43L44LL44T45TT45R46RR46K47KK47... and 34 more residue(s)...... and 34 more residue(s)

SMILES None
InChIKey None
Sequence AVITGACDKDSQCGGGMCCAVSIWVKSIRICTPMGKLGDSCHPLTRKVPFFGRRMHHTCPCLPGLACLRTSFNRFICLAQK

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

prokineticin-2β

A1AA1V2VV2I3II3T4TT4G5GG5A6AA6C7CC7D8DD8K9KK9D10DD10S11SS11Q12QQ12C13CC13G14GG14G15GG15G16GG16M17MM17C18CC18C19CC19A20AA20V21VV21S22SS22I23II23W24WW24V25VV25K26KK26S27SS27I28II28R29RR29I30II30C31CC31T32TT32P33PP33M34MM34G35GG35K36KK36L37LL37G38GG38D39DD39S40SS40C41CC41H42HH42P43PP43L44LL44T45TT45R46RR46K47KK47... and 34 more residue(s)...... and 34 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.